Jiangsu Hualan New Pharmaceutical Material Co.,Ltd. (SHE:301093)
China · Delayed Price · Currency is CNY 84.35
+9.57 (12.80%)
At close: Jan 23, 2026
SHE:301093 Revenue
Jiangsu Hualan New Pharmaceutical Material had revenue of 132.48M CNY in the quarter ending September 30, 2025, a decrease of -4.72%. This brings the company's revenue in the last twelve months to 604.86M, up 2.18% year-over-year. In the year 2024, Jiangsu Hualan New Pharmaceutical Material had annual revenue of 586.41M, down -5.86%.
Revenue (ttm)
604.86M
Revenue Growth
+2.18%
P/S Ratio
22.48
Revenue / Employee
650.39K
Employees
930
Market Cap
13.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 586.41M | -36.51M | -5.86% |
| Dec 31, 2023 | 622.92M | 38.79M | 6.64% |
| Jan 1, 2023 | 584.14M | -236.73M | -28.84% |
| Jan 1, 2022 | 820.87M | 374.54M | 83.92% |
| Dec 31, 2020 | 446.32M | -13.42M | -2.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Truking Technology | 5.55B |
| Tofflon Science and Technology Group | 5.22B |
| Zhende Medical | 4.32B |
| Micro-Tech (Nanjing) Co.,Ltd | 3.12B |
| Shenyang Xingqi Pharmaceutical | 2.41B |
| Autek China | 1.82B |
| Sansure Biotech | 1.67B |
| Andon Health | 1.57B |